LSPN North America

Protect and leverage your IP across the life cycle of innovation

October 15-16, 2024 - Hyatt Regency, San Francisco

150+ Attendees

50+ Speakers

16+ Sessions

Don’t miss the leading event for IP professionals in the life sciences!

Hot on the heels of our biggest event ever, LSPN Fall will be taking place on October 15 and 16 in San Francisco, this industry-leading event presents an unrivalled gathering of in-house patent counsel from leading pharmaceutical and biotechnology companies.

Every year, hundreds of IP professionals rely on our Life Sciences Patent Network conferences to get insights into sector issues of critical importance and stay abreast of the likely forward impact of key judgments and political jolts. This year's conference is set to be bigger than ever, you don’t want to miss the biggest gathering of life science patent attorneys on the West Coast. By attending you will secure a chunk of your CLE credits for the year, and walk away with tangible tips to apply to your practice.

Leading companies who register to attend our LSPN events include Alnylam Pharmaceuticals, Genentech, AstraZeneca, Boehringer Ingelheim, Arbor Technologies, Galapagos, Millipore Sigma, GSK, Novartis, Prolacta Bioscience, Amunix Pharmaceuticals, BioInfi, Merck, TherapeuticsMD, Pieris Pharmaceuticals, Tessa Therapeutics, Takeda, Agilent Technologies and more!

LSPN provides a comprehensive platform for the most innovative patent holders in the industry to address the challenges they face and explore solutions. By bringing together industry experts, legal professionals, and representatives from various sectors we offer a unique opportunity to exchange knowledge, share best practices, and forge valuable connections. Previous delegates include:

Connect with industry leaders from some of the most innovative pharma and biotech companies across the globe:

Address the biggest challenges and opportunities for leveraging your IP - find out how to:

● Maximize your chance of success with better strategies during the application and prosecution stage of patent management

● Integrate regulatory considerations into your IP strategy to protect your innovation from conception, through clinical trials, and onto the market.

● Navigate post grant proceedings and litigation once you have secured your patent

● Exploit the benefits of emerging technologies, utilising AI, machine learning, CRISPR and gene therapies

● Overcome the latest challenges brought about by the ever shifting legal landscape by taking home insights from your peers who have already mastered them

This year’s programme is specifically tailored to cover every aspect of patent management across the life cycle of your product.

● The right mix of people - We always ensure at least 50% of our audience come from in-house positions within pharma, biotech, and medtech companies so you’ll enjoy making connections with potential clients, or speak with peers to see how they are tackling their challenges.

● The right balance of education and business orientated-come to learn from your peers and brush up on the latest topics, and walk away with new and valuable associations.

● The right mix of presentations from experts, panel discussions to explore varying perspectives, and roundtables for informal and informative discussions with your peers - so you gain real insights from like-minded professionals and know what the groupthink is.

Key themes for 2024 include:

● Examine the IP landscape-Jurisdictional overview

Delve into patent eligibility criteria, prosecution strategies, emerging technologies, and ethical considerations across patent landscapes in US, Asian, and European including

● Essential considerations in patenting and clinical trials

Discuss the intersection between patenting and clinical trials within the dynamic IP landscape in the life sciences industries

● Hear strategies for success: patent drafting and application
Join us for a master class in patent drafting for successful applications to the USPTO

● AI and machine learning in drug discovery: patenting AI-generated inventions

Navigate the new guidelines with robust patent claims, and find out how to ensure the human contribution to innovation is significant enough to qualify for a patent

● Navigate enablement and written description requirement standards in the USPTO

Debate the significant shift in patent law in the United States in the context of the new guidelines on enablement issued by the director of the USPTO under 35 U.S.C §112

This year’s programme is specifically tailored to cover every aspect of patent management across the life cycle of your product.

The right mix of people - We always ensure at least 50% of our audience come from in-house positions within pharma, biotech, and medtech companies so you’ll enjoy making connections with potential clients, or speak with peers to see how they are tackling their challenges.

The Right balance of education and business orientated - come to learn from your peers and brush up on the latest topics, and walk away with new and valuable associations.

The right mix of presentations from experts, panel discussions to explore varying perspectives, and roundtables for informal and informative discussions with your peers - so you gain real insights from like-minded professionals and know what the groupthink is.